SIRT6 Inhibits Anoikis of Colorectal Cancer Cells by Down-Regulating NDRG1

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Anoikis, a form of programmed cell death, is crucial for preventing cancer cell metastasis.
• The epigenetic mechanisms governing anoikis resistance in colorectal cancer (CRC) are not fully understood.

Purpose of the Study:

• To investigate the role of histone deacetylase sirtuin 6 (SIRT6) in regulating anoikis in colorectal cancer cells.
• To elucidate the molecular mechanisms by which SIRT6 influences anoikis resistance and CRC progression.

Main Methods:

• Assessing SIRT6 protein levels in CRC cells and patient samples.
• Manipulating SIRT6 expression (overexpression and knockdown) to evaluate its impact on anoikis.
• Analyzing the transcriptional regulation of N-myc downstream-regulated gene 1 (NDRG1) by SIRT6.
• Investigating the effect of SIRT6 on the AKT signaling pathway.

Main Results:

• SIRT6 protein levels are inversely correlated with anoikis in CRC cells.
• SIRT6 overexpression enhances anoikis resistance, while SIRT6 knockdown increases detachment-induced anoikis.
• SIRT6 suppresses the transcription of NDRG1, a negative regulator of AKT signaling.
• SIRT6 is upregulated in advanced-stage CRC samples.

Conclusions:

• SIRT6 plays a critical role in conferring anoikis resistance to colorectal cancer cells.
• SIRT6 epigenetically regulates anoikis by inhibiting NDRG1 transcription and modulating AKT signaling.
• The findings reveal a novel epigenetic mechanism underlying CRC metastasis and suggest SIRT6 as a potential therapeutic target.